Abstract
The dopaminergic (DA) substantia nigra-ventral tegmental area (SN-VTA) projection to the caudate-putamen (striatum) is critical in the control of motor behavior. Clinically, Parkinson’s disease reflects a massive degeneration of the nigrostriatal system (Bernheimer et al., 1973). The replacement of the system by intrastriatal transplants of fetal midbrain suspensions has resulted in improvements in some patients (Sladek and Shoulson, 1988; Lindvall et al., 1989; Freed et al., 1990). In experimental animals, it has been shown that fetal midbrain cells survive transplantation, extend processes and synthesize DA (Perlow et al., 1979; Björklund et al., 1980, 1983a, 1983b). Such transplants ameliorate certain deficits associated with the loss of DA input to the striatum (Björklund et al., 1987; Yurek and Sladek, 1990). Similar transplants reverse motor abnormalities produced by unilateral denervation (Perlow et al, 1979; Björklund et al, 1980, 1983a, 1983b) including apomorphine or amphetamine-induced rotation behavior. Transplants of adrenal medulla have also been shown to ameliorate some behavioral deficits (Allen et al., 1989; Hansen et al., 1989; Lieberman et al., 1989).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alexi, T., Hefti, F., 1993, Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture, Neuroscience in press.
Alexi, T., Denton, T.L., Hefti, F., 1991, Effects of TGF-alpha and TGF-beta on ventral mesencephalic dopaminergic cultures, Neurosci. Abst. 17.
Allen, G.S., Burns, S., Tulipan, N.B., and Parker, R.A., 1989, Adrenal medullary transplantation to the caudate nucleus in Parkinson’s Disease, Arch Neurol. 46:487–491.
Bankiewicz, K.S., Plunkett, R.J., Jacobowitz, D.M., Kopin, I.J., and Oldfield, E.H., 1991, Fetal nondopaminergic neural implants in parkinsonian primates, J. Neurosurg. 74:97–104.
Bean, A.J., Elde, R., Cao, Y., Oellig, C, Tamminga, C, Goldstein, M., Pettersson, R.F., Hokfelt, T.,1991, Expression of acidic and basic fibroblast growth factors in die substantia nigra of rat, monkey,and human,Proc. Natl Acad. Sci. 88:10237–10241.
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., and Seitelberger, K., 1973, Brain dopamine and the syndrome of Parkinson and Huntington:Clinical, morphological, and neurochemical correlations, J. Neurol. Sci. 20:415–455.
Bjorklund, A., Schmidt, R.H., and Stenevi, U., 1980, Functional re-innervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra, Cell Tiss. Res. 212:39–45.
Bjorklund, A., Stenevi, U., Schmidt, R.H., Dunnett, S.B., and Gage, F.H., 1983a, Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation, Acta Physiol. Scand., Suppl. 522:1–7.
Bjorklund, A., Stenevi, U., Schmidt, R.H., Dunnett, S.B., and Gage, F.H., 1983b, Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites, Acta Physiol. Scand., Suppl. 522:9–16.
Bjorklund, A., Lindvall, O., Isacson, O., Brundin, P., Wictorin, K., Strecker, R.E., Clarke, D.J., and Dunnett, S.B., 1987, Mechanisms of action of intracerebral neural implants:studies of nigral and striatal grafts to the lesioned striatum, Trends Neurosci. 10:509–516.
Bohn, M.C., Cupit, L., Marciano, F., and Gash, D.M., 1987, Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers, Science 237:913–916.
Bregman, B.S., and Reier, P.J., 1986, Neural tissue transplants rescue axotomized rubrospinal cells from retrograde death, J. Comp. Neurol. 244:86–95.
Bringman, T.S., Lindquist, P.B., and Derynck, R., 1987, Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor, Cell48:429–440.
Burgess, A.W., 1989, Epidermal growth factor and transforming growth factor alpha, British Medical Bulletin 45(2):401–424.
Casper, D., Mytilineou, C, and Blum, M., 1991, EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture, J. Neurosci. Res. 30:372–381.
Chalazonitis, A., Kessler, J.A., Twardzik, D.R., and Morrison, R.S., 1992, Transforming growth factor alpha, but not epidermal growth factor, promotes the survival of sensory neurons in vitro, J. Neurosci. 12(2):583–594.
Code, R.A., Seroogy, K.B., and Fallon, J.H., 1987, Some transforming growth factor-alpha connections and their colocalization with enkephalin in the rat central nervous system, Brain Res. 421:401–405.
De Larco, J.E., and Todaro, G.J., 1978, Growth factors from murine sarcoma virus-transformed cells, Proc. Nat. Acad. Sci. 75:4001–4005.
Derynck, R., Roberts, A.B., Winkler, M.E., Chen, E.Y., Goeddel, D.V.,1984, Human transforming growth factor alpha: Precursor structure and expression in E. coli, Cell 38:287–297.
Derynck, R., 1987, Structure of transforming growth factors -a and -ß and their precursors, in: “Oncogenes, Genes, and Growth Factors,” G. Guroff, ed., John Wiley and Sons, New York, pp. 133–163.
Ebner, R., and Derynck, R., 1991, Epidermal growth factor and transforming growth factor-alpha:Differential intracellular routing and processing of ligand-receptor complexes, Cell Regulation 2:599–612.
Fallon, J.H., Di Salvo, J., Loughlin, S.E., Gimenez–Gallago, G., Seroogy, K.B., Bradshaw, R.A., Morrison, R.S., Ciofi, P., and Thomas, K.A., 1992, Localization of acidic fibroblast growth factor within the mouse brain using biochemical and immunocytochemical techniques, Growth Factors 6:139–157.
Fallon, J.H., Loughlin, S.E., Annis, CM., Gentry, L., and Twardzik, D., 1990, Localization of cells containing transforming growth factor alpha precursor immunoreactivity in the basal ganglia of the adult rat brain, Growth Factors 2:241–250.
Fallon, J.H., Loughlin, S.E., 1987, Monoamine innervation of cerebral cortex and a theory of the role of monoamines in cerebral cortex and basal ganglia, in: “Cerebral Cortex, Vol. 6,” E.G. Jones, D.Peters, eds., Plenum Press, New York pp. 41–127.
Fallon, A.H., Loughlin, S.E., 1993, Functional implications of the anatomical localization of neurotrophic factors, in: “Neurotrophic Factors,” S.E. Loughlin, J.H. Fallon, eds., Academic Press, San Diego pp. 1–24.
Freed, C.R., Breeze, R.E., Rosenberg, N.L., Schneck, S.A., Wells, T.H., Barrett, J.N., Grafton, ST., Mazziotta, J.C., Eidelberg, D., and Rottenberg, D.A., 1990, Therapeutic effects of human fetal dopamine cells transplanted in a patient with Parkinson’s disease, Progress Brain Res. 82:715–721.
Freed, W.J., and Cannon-Spoor, H.E., 1988, Cortical lesions increase reinnervation of the dorsal striatum by substantia nigra grafts, Brain Res. 446:133–143.
Gall, CM., Gold, S.J., Isackson, P.J., and Seroogy, K.B., 1992, Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons, Mol. Cell. Neurosci. 3:56–63.
Gentry, L.E., Twardzik, D.R., Lim, G.J., Ranchalis, J.E., and Lee, D.C, 1987, Expression and characterization of transforming growth factor precursor protein in transfected mammalian cells, Mol. and Cell. Biol. 7(5):1585–1591.
Hadjiconstantinou, M., Fitkin, J.G., Dalia, A., and Neff, N.H., 1991, Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, J. Neurochem. 57(2):479–482.
Hansen, J.T., Bing, G., Notter, M.F.D., and Kordower, J.H., 1989, Adrenal chromaffin cells as transplants in animal models of Parkinson’s Disease, J. Electron Microscopy Technique 12:308–315.
Hefti, F., Denton, T.L., Knusel, B., Lapchak, P.A., 1993, Neurotrophic factors: What are they and what are they doing?, in: “Neurotrophic Factors,” S.E. Loughlin, J.H. Fallon, eds., Academic Press, San Diego, pp. 25–50.
Hofer, M., Pagliusi, S.R., Hohn, A., Leibrock, J., and Barde, Y.-A., 1990, Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain, EMBO J9:2459–2464.
Hyman, C, Hofer, M., Barde, Y.-A., Juhasz, M., Yancopoulos, G.D., Squinto, S. P., Lindsay, R.M., 1991, BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra, Nature 350:230–232.
Junier, M.-P., Ma, Y.J., Costa, M.E., Hoffman, G., Hill, D.F., Ojeda, S.R., 1991, Transforming growth factor alpha contributes to the mechanism by which hypothalamic injury induces precocious puberty, Proc. Natl. Acad. Sci. USA 88:9743–9747.
Knusel, B., Michel, P.P., Schwaber, J.S., Hefti, F., 1990, Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II, J. Neurosci. 10(2):558–570.
Korc, M., Chandrasekar, B., and Shah, G., 1991, Differential binding and biological activities of epidermal growth factor and transforming growth factor alpha in a human pancreatic cancer cell line, Cancer Res 51,6243–6249.
Kromer, L.F., Bjorklund, A., and Stenevi, U., 1981, Regeneration of the septohippocampal pathways in adult rats is promoted by utilizing embryonic hippocampal implants as bridges, Brain Res. 210:173–200.
Kudlow, J.E., Leung, A.W.C., Kobrin, M.S., Paterson, A.J., and Asa, S.L., 1989, Transforming growth factor-a in the mammalian brain, J. Biol. Chem. 264:3880–3883.
Lazar, L.M., and Blum, M., 1992, Regional distribution and developmental expression of epidermal growth factor and transforming growth factor — alpha mRNA in mouse brain by a quantitative nuclease protection assay, J. Neurosci. 12(5):1688–1697.
Lee, D.C., Rochford, R., Todaro, G.J., Villarreal, L.P., 1985a, Developmental expression of rat transforming growth factor-alpha mRNA, Mol. and Cell. Biol. Dec.:3644–3646.
Lee, D.C., Rose, T.M., Webb, N.R., and Todaro, G.J., 1985b, Cloning and sequence analysis of a cDNA for rat transforming growth factor-a, Nature 313:489–491.
Lieberman, A., Ransohoff, J., Berczeller, P., Brous, P., Eng, K., Goldstein, M., Kaufman, B., Koslow, M.,and Chin, L., 1989, Adrenal medullary transplants as a treatment for advanced Parkinson’s Disease, ActaNeurol. Scand. 126:189–196.
Lindvall, O., Rehncrona, S., Brundin, P., Gustavii, B., Astedt, B., Widner, H., Lindholm, T., Björklund, A.,Leenders, K., Rothwell, J., Frackowiak, R., Marsden, CD., Johnels, B., Steg, G., Freedman, R., Hoffer, B., Seiger, A., Bygdeman, M.,Stromberg, I., Olson, L., 1989, Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson’s disease: A detailed account of methodology and a 6-month follow-up, Arch. Neurol. 46:615–631.
Loughlin, S.E., Baratta, J., Gentry, L., Twardzik, D., Annis, CM., and Fallon, L.H., Transforming growth factor alpha precursor immunoreactive astrocytes:Modulation by injury and transplants of fetal suspensions, in preparation.
Loughlin, S.E., Annis, CM., Twardzik, D.R., Lee, D.C, Gentry, L., and Fallon, J.H., 1989, Growth factors in opioid rich brain regions:Distribution and response to intrastriatal transplants, Adv. Biosci. 75:403–406.
Loughlin, S.E., Fallon, J.H., 1993, “Neurotrophic Factors,” Academic Press, San Diego.
Lu, S.Y., Shipley, M.T., Norman, A.B., and Sanberg, P.R., 1991, Striatal, ventral mesencephalic and cortical transplants into the intact rat striatum:A neuroanatomical study, Exp. Neurol. 113:109–130.
Lu, S.Y., Giordano, M., Norman, A.B., Shipley, M.T., and Sanberg, P.R., 1990, Behavioral effects of fetal tissue transplants into the intact striatum, Pharm. Biochem. Behav. 27:1–14.
Mattioli, R., Schwarting, R.K.W., and Huston, J.P., 1992, Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P1–11,Neuroscience 48 (3):595–605.
Massague, J., 1983, Epidermal growth factor-like transforming growth factor receptors in human plasma membranes on A432 cells, J. Biol. Chem. 258:13614–13620.
Missale, C, Castelletti, L., Boroni, F., Memo, M., and Spano, P., 1991, Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line, Endocrinology 128 (1):13–20.
O’Malley, E.K., Black, I.B., and Dreyfus, C.F., 1991, Local support cells promote survivial of substantia nigra dopaminergic neurons in culture, Exp. Neurol. 112:4048.
O’Malley, K.L., and Wagner, C, 1988, Growth factor effects on tyrosine hydroxylase messenger RNA in rat pheochromocytoma cell lines, in: “Progress in Catecholamine Research,” A. Dahlstrom, R. Belmaker and M. Sandler, eds., Alan R. Liss, New York, pp. 35–40.
Perlow, M.J., Freed, W.J., Hoffer, B.J., Seiger, A., Olson, L., and Wyatt, R.J., 1979, Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system, Science 204:643–646.
Pezzoli, G., Fahn, S., Dwork, A., Truong, D.D., de Yebenes, J. G., Jackson-Lewis, V., Herbert, J., and Cadet, J.L., 1988, Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged rats, Brain Res. 459:398–403.
Pezzoli, G., Zecchinelli, A., Ricciardi, S., Burke, R.E., Fahn, S., Scartato, G., and Carenzi, A., 1991, Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats, Movement Disorders 6 (4):281–287.
Proper, J.A., Bjornson, C.L., and Moses, H.L., 1980, Mouse embryos contain polypeptide growth factors capable of inducing a reversible neoplastic phenotype in non-transformed cells in culture, J. Cell Physiol. 110:169–174.
Puolakkainen, P., Twardzik, D.R., 1993, Transforming growth factors alpha and beta, in: “Neurotrophic Factors,” S.E. Loughlin, J.H. Fallon, eds., Academic Press, San Diego, pp. 359–390.
Rappolee, D.A., Mark, D., Banda, M.J., and Werb, Z., 1988, Wound macrophages express TGF alpha and other growth factors in vivo:Analysis by mRNA phenotyping, Science 241:708–712.
Reynolds, B.A., Tetzlaff, W., and Weiss, S., 1990, EGF- and TGF alpha — responsive striatal embryonic progenitor cells produce both neurons and astrocytes, Abstr. Soc. Neurosci. 474 (2).
Reynolds, B.A., Weiss, S., 1992.,Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, Science 255:1707–1709.
Rousselet, A., Fetler, L., Chamak, B., and Prochiantz, A., 1988, Rat mesencephalic neurons in culture exhibit different morphological traits in the presence of media conditioned on mesencephalic or striatal astroglia, Developmental Biology. 129:495–504.
Sanberg, P.R., Nash, D.R., Calderon, S.F., Giordano, M., Shipley, M.T., and Norman, A.B., 1988, Neural transplants disrupt the blood-brain barrier and allow peripherally acting drugs to exert a centrally mediated behavioral effect, Exp. Neurol. 102:149–152.
Schneider, J.S., Pope, A., Simpson, K., Taggart, J., Smith, M.G., and DiStefano, L., 1992, Recovery from experimental Parkinsonism in primates with GM1 ganglioside treatment, Science 256:843–846.
Seroogy, K.B., Lundgren, K.H., Lee, D.C., Guthrie, K.M., Gall, CM., 1993, Cellular localization of transforming growth factor alpha mRNA in rat forebrain, J. Neurochem. in press.
Sladek, J.R., Jr., and Shoulson, I., 1988, Neural transplantation:A call for patience rather than patients, Science 240:1386–1388.
Spina, M.B., Squinto, S.P., Miller, J., Lindsay, R.M., and Hyman, C, 1992, Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity:Involvement of the glutathione system, J. Neurochem. 59:99–106.
Tam, J.P., 1985, Physiological effects of transforming growth factor in the newborn mouse, Science 229:673–675.
Todaro, G.J., Fryling, C, and De Larco, J.E., 1980, Transforming growth factors produced by certain human tumor cells:polypeptides that interact with epidermal growth factor receptors, Proc. Natl. Acad. Sci. (USA) 77:5258–5262.
Twardzik, D.R., 1985. Differential expression of transforming growth factor-a during prenatal development of the mouse, Cancer Res. 45:5413–5416.
Twardzik, D.R., Todaro, G.J., Reynolds, F.H., Jr., and Stephenson, J.R., 1982, Abelson MuLV induced transformation involves production of a polypeptide growth factor, Science 216:894–897.
Twardzik, D.R., Ranchalis, J.E., 1987, Growth modulating peptides that utilize the receptor for epidermal growth factor, Bone Matrix 421–437.
Whitaker-Azmitia, P.M., Ramirez, A., Noreika, L., Gannon, P.J., Azmitia, E.C., 1987, Onset and duration of astrocytic response to cells transplanted into the adult mammalian brain, in: “Cell Tissue Transplantation Into the Adult Brain,” E.C. Azmitia, A. Bjorklund, eds., New York Academy Press, New York., pp. 10–23.
Wilcox, J.N., and Derynck, R., 1988, Localization of cells synthesizing transforming growth factor-alpha mRNA in the mouse brain, J. Neurosci. 8 (6):1901–1904.
Yurek, D.M., and Sladek, J.R., Jr., 1990, Dopamine cell replacement:Parkinson’s Disease, Annu. Rev. Neurosci. 13:415–440.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Plenum Press, New York
About this chapter
Cite this chapter
Loughlin, S.E., Lee, T.P., Fallon, J.H. (1994). Efficacy of Intrastriatal Transplants: Role of Trophic Factors. In: Percheron, G., McKenzie, J.S., Féger, J. (eds) The Basal Ganglia IV. Advances in Behavioral Biology, vol 41. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0485-2_22
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0485-2_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7591-6
Online ISBN: 978-1-4613-0485-2
eBook Packages: Springer Book Archive